Mitoimmune Therapeutics
Mito Immune Therapeutics is a drug research and development biotech company.
Mitoimmune Therapeutics is a business in biotechnology, medical, pharmaceutical based in Asia-Pacific (APAC), founded in 2018.
Within the biotechnology, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Asia-Pacific (APAC).
It is recorded at the Series_B stage.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $39.5B.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $39,500,000,000 |
Website: mitoimmune.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account